Associations Between Hepatic Functions and Plasma Amyloid-Beta Levels—Implications for the Capacity of Liver in Peripheral Amyloid-Beta Clearance
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Associations Between Hepatic Functions and Plasma Amyloid-Beta Levels—Implications for the Capacity of Liver in Peripheral Amyloid-Beta Clearance
Authors
Keywords
Alzheimer’s disease, Amyloid-beta, Hepatic dysfunction, Liver cirrhosis
Journal
MOLECULAR NEUROBIOLOGY
Volume 54, Issue 3, Pages 2338-2344
Publisher
Springer Nature
Online
2016-03-09
DOI
10.1007/s12035-016-9826-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Physiological amyloid-beta clearance in the periphery and its therapeutic potential for Alzheimer’s disease
- (2015) Yang Xiang et al. ACTA NEUROPATHOLOGICA
- A prospective study on blood Aβ levels and the cognitive function of patients with hemodialysis: a potential therapeutic strategy for Alzheimer’s disease
- (2015) Nobuya Kitaguchi et al. JOURNAL OF NEURAL TRANSMISSION
- Amyloid-β efflux from the central nervous system into the plasma
- (2014) Kaleigh Filisa Roberts et al. ANNALS OF NEUROLOGY
- Lessons from a Failed γ-Secretase Alzheimer Trial
- (2014) Bart De Strooper CELL
- A study on the association between infectious burden and Alzheimer's disease
- (2014) X.-L. Bu et al. EUROPEAN JOURNAL OF NEUROLOGY
- Clearance of Amyloid-Beta in Alzheimer’s Disease: Shifting the Action Site from Center to Periphery
- (2014) Yu-Hui Liu et al. MOLECULAR NEUROBIOLOGY
- Association Between Serum Amyloid-Beta and Renal Functions: Implications for Roles of Kidney in Amyloid-Beta Clearance
- (2014) Yu-Hui Liu et al. MOLECULAR NEUROBIOLOGY
- HDL and cognition in neurodegenerative disorders
- (2014) David A. Hottman et al. NEUROBIOLOGY OF DISEASE
- Immunity and Alzheimer's disease: immunological perspectives on the development of novel therapies
- (2013) Yu-Hui Liu et al. DRUG DISCOVERY TODAY
- Human Serum Albumin Can Regulate Amyloid-β Peptide Fiber Growth in the Brain Interstitium
- (2012) Helen F. Stanyon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Immunotherapy for Alzheimer disease—the challenge of adverse effects
- (2012) Yu-Hui Liu et al. Nature Reviews Neurology
- Association of Alzheimer Disease Pathology with Abnormal Lipid Metabolism: The Hisayama Study
- (2012) G. T. Lesser NEUROLOGY
- Low-density lipoprotein receptor-related protein 1: A physiological Aβ homeostatic mechanism with multiple therapeutic opportunities
- (2012) Abhay P. Sagare et al. PHARMACOLOGY & THERAPEUTICS
- Withania somnifera reverses Alzheimer's disease pathology by enhancing low-density lipoprotein receptor-related protein in liver
- (2012) N. Sehgal et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics
- (2011) Eric Karran et al. NATURE REVIEWS DRUG DISCOVERY
- Vascular risk factors promote conversion from mild cognitive impairment to Alzheimer disease
- (2011) J. Li et al. NEUROLOGY
- Fatty acids, lipid metabolism and Alzheimer pathology
- (2008) Carlijn R. Hooijmans et al. EUROPEAN JOURNAL OF PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation